Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 10 de 10
Filtrar
1.
Cancer Med ; 7(12): 6084-6092, 2018 12.
Artículo en Inglés | MEDLINE | ID: mdl-30453386

RESUMEN

BACKGROUND: Doxorubicin is a typical anticancer drug that causes cardiomyopathy and heart failure (HF). The aim of our study was to investigate incidence, risk factors for doxorubicin-induced HF in Korean cancer patients and their survival rate, utilizing a nationwide population-based cohort. METHODS: We analyzed 58 541 cancer patients who received doxorubicin between 2003 and 2010. Descriptive analysis was performed in patients with breast cancer, hematologic malignancy, gynecological malignancy, and sarcoma. Risk factors associated with doxorubicin-induced HF were investigated using a Cox proportional hazards model. The survival rate of doxorubicin-induced HF patients was compared with that of patients without doxorubicin-induced HF. RESULTS: A total of 2324 (4%) were diagnosed with doxorubicin-induced HF. In patients with breast cancer, predictive risk factors for doxorubicin-induced HF included age over 65 years [hazard ratio (HR) 1.34, 95% confidence interval (CI) 1.05-1.72], hypertension [HR 2.45 (2.12- 2.84)], diabetes mellitus [HR 1.26 (1.05-1.51)], coronary artery disease [HR 2.08 (1.63-2.66)], advanced stage [HR 1.31 (1.13-1.50)], and trastuzumab administration [HR 2.94 (2.54-3.40)]. In patients with hematologic malignancy, predictive risk factors included age over 65 years [HR 1.75 (1.49-2.07)], hypertension [HR 1.62 (1.37-1.92)], and coronary artery disease [HR 2.28 (1.80-2.89)]. Five-year survival rates of patients with doxorubicin-induced HF were significantly lower relative to those of patients without HF in breast cancer and hematologic malignancy: 80% vs 84% and 69% vs 75%, respectively (P < 0.001). CONCLUSIONS: In cancer patients treated with doxorubicin, management of risk factors, early detection, and treatment for doxorubicin-induced HF might be critical for patient survival.


Asunto(s)
Antibióticos Antineoplásicos/efectos adversos , Doxorrubicina/efectos adversos , Insuficiencia Cardíaca/inducido químicamente , Adulto , Anciano , Estudios de Cohortes , Bases de Datos Factuales , Femenino , Humanos , Masculino , Persona de Mediana Edad , Programas Nacionales de Salud , Modelos de Riesgos Proporcionales , República de Corea , Factores de Riesgo
2.
Obes Res Clin Pract ; 12(4): 389-393, 2018.
Artículo en Inglés | MEDLINE | ID: mdl-28522388

RESUMEN

As the prevalence of morbid obesity increased in Korea, the estimation of the accurate socioeconomic costs by morbid obesity was required; we analysed national medical costs through the big data. From 2009 year to 2013 year, Direct Costs (DC) for medical costs, transit costs and nursing costs and Indirect Costs (IC) for Future Income Loss (FIL) and Productivity Loss (PL) of morbid obesity (BMI≥30) were calculated, and socioeconomic costs were estimated by applying Population Attributable Risk (PAR) proportion according to obesity related diseases. From 10 year follow up research, Relative risk (RR) for morbid obesity related disease was analysed in comparison with control group. The high RR disease were congestive heart failure (RR 3.204 CI 2.421-3.987), hypertension (RR 3.13 CI 3.058-3.202), type 2 DM (RR 3.112 CI 2.973-3.251), pulmonary embolism (RR 2.969 CI 1.812-4.126), dyslipidemia (RR 2.283 CI 2.221-2.345) and ischaemic heart disease (RR 2.187 CI 2.068-2.306) in order. The socioeconomic costs by morbid obesity tended to increase 1.47 times from 2009 year (492 billion KRW) to 2013 year (726.2 billion KRW). The growth of the prevalence and the socioeconomic costs by morbid obesity in Korea are required not only the personal care issue but also social and national strategies for the future morbid obesity control.


Asunto(s)
Costo de Enfermedad , Costos de la Atención en Salud , Obesidad Mórbida/economía , Adulto , Femenino , Humanos , Masculino , Persona de Mediana Edad , Programas Nacionales de Salud , Obesidad Mórbida/epidemiología , Prevalencia , República de Corea , Factores Socioeconómicos
3.
Bioresour Technol ; 222: 422-430, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-27744166

RESUMEN

The efficient fermentation of lignocellulosic hydrolysates in the presence of inhibitors is highly desirable for bioethanol production. Among the inhibitors, acetic acid released during the pretreatment of lignocellulose negatively affects the fermentation performance of biofuel producing organisms. In this study, we evaluated the inhibitory effects of acetic acid on glucose and xylose fermentation by a high performance engineered strain of xylose utilizing Saccharomyces cerevisiae, SXA-R2P-E, harboring a xylose isomerase based pathway. The presence of acetic acid severely decreased the xylose fermentation performance of this strain. However, the acetic acid stress was alleviated by metal ion supplementation resulting in a 52% increased ethanol production rate under 2g/L of acetic acid stress. This study shows the inhibitory effect of acetic acid on an engineered isomerase-based xylose utilizing strain and suggests a simple but effective method to improve the co-fermentation performance under acetic acid stress for efficient bioethanol production.


Asunto(s)
Ácido Acético/metabolismo , Isomerasas Aldosa-Cetosa/metabolismo , Etanol/metabolismo , Manganeso/metabolismo , Saccharomyces cerevisiae/metabolismo , Biocombustibles , Biotecnología/métodos , Fermentación , Glucosa/metabolismo , Lignina/química , Lignina/metabolismo , Manganeso/farmacología , Saccharomyces cerevisiae/efectos de los fármacos , Xilosa/metabolismo
4.
Health Econ ; 25(10): 1239-51, 2016 10.
Artículo en Inglés | MEDLINE | ID: mdl-26085120

RESUMEN

Korea's rapid population aging has been considered as a major factor in increase of healthcare expenditure (HCE). However, there were no clear empirical evidences in Korea that show if population aging has a significant impact on HCE. To examine the 'red herring' argument, this study used Heckman, two-part, and augmented model with Korean National Health Insurance claim data for the deceased and survivors of aged 20 years and over verified by Korean National Health Insurance Service between January 1 and December 31, 2010. Our results suggest that when time to death is controlled for as explanatory variable, HCE decreases as a function of age, and HCE during the terminal year increases as a function of time to death, and HCE in the last quarter of life decreases with age. Therefore, this study affirms that there is no age effect in Korea experiencing the most rapid population aging among Asian countries. An increase in the number of elderly, due to the aging of baby boomers, may not increase a share of HCE out of gross domestic product (GDP) in Korea. Copyright © 2015 John Wiley & Sons, Ltd.


Asunto(s)
Envejecimiento , Gastos en Salud/estadística & datos numéricos , Revisión de Utilización de Seguros/estadística & datos numéricos , Adulto , Anciano , Femenino , Gastos en Salud/tendencias , Humanos , Esperanza de Vida/tendencias , Masculino , Persona de Mediana Edad , Programas Nacionales de Salud , República de Corea
5.
BMC Health Serv Res ; 14: 630, 2014 Dec 21.
Artículo en Inglés | MEDLINE | ID: mdl-25528468

RESUMEN

BACKGROUND: This study examines the effects of long-term care insurance (LTCI) on the length of stay (LoS) of senior citizens under the national health insurance of Korea. METHODS: The subjects include 3,903,448 people aged 65 and over as of July 1, 2008 when the LTCI was introduced in Korea. This study uses their panel data which traced the records of medical services and LTCI services for the same people from 2007 to 2010, and applies a difference-in-difference approach on LTCI users from levels 1, 2, and 3 who are the treatment group and non-LTCI users who are the control group. RESULTS: We found that the LoS of LTCI users is 1.27 days greater than that of non-LTCI users, but the LoS of level 1 and level 2 beneficiaries decreases by 8.35 and 2.84 days, respectively, whereas the LTCI does not reduce the LoS of level 3 beneficiaries. CONCLUSIONS: The reason why there is an effect on the LoS of level 1 and 2 beneficiaries is that these groups could choose to utilize institutional care services provided by the LTCI, and out-of-pocket costs of institutions are lower than that of hospitals. However, the reason why there is no effect on the LoS of level 3 beneficiaries is that they are not permitted to use the institutional care services in the Korean LTCI policy. Therefore, we recommend a modification in the LTCI system that facilitates the use of long-term care institutional services by level 3 beneficiaries without conflicting Korea's LTCI principle to promote home-based care services instead of the institutional care services.


Asunto(s)
Hospitalización , Seguro de Cuidados a Largo Plazo , Tiempo de Internación , Anciano , Anciano de 80 o más Años , Femenino , Gastos en Salud , Servicios de Atención de Salud a Domicilio , Humanos , Seguro de Cuidados a Largo Plazo/economía , Tiempo de Internación/economía , Masculino , Programas Nacionales de Salud , República de Corea
6.
ACS Nano ; 7(1): 50-7, 2013 Jan 22.
Artículo en Inglés | MEDLINE | ID: mdl-23194301

RESUMEN

We have developed RGD-attached gold (Au) half-shell nanoparticles containing methotrexate (MTX) for the treatment of rheumatoid arthritis (RA), where MTX is the most widely used disease-modifying anti-rheumatic drug (DMARD) for the treatment of RA, and RGD peptide is a targeting moiety for inflammation. Upon near-infrared (NIR) irradiation, heat is locally generated due to Au half-shells, and the drug release rate is enhanced, delivering heat and drug to the inflamed joints simultaneously. RA is a chronic inflammatory disease characterized by synovial inflammation in multiple joints within the penetration depth of NIR light. When combined with NIR irradiation, these nanoparticles containing a much smaller dosage of MTX (1/930 of MTX solution) showed greater therapeutic effects than that of a conventional treatment with MTX solution in collagen-induced arthritic mice. This novel drug delivery system is a good way to maximize therapeutic efficacy and minimize dosage-related MTX side effects in the treatment of RA. Furthermore, these multifunctional nanoparticles could be applied to other DMARDs for RA or other inflammatory diseases.


Asunto(s)
Artritis Reumatoide/terapia , Oro/uso terapéutico , Hipertermia Inducida/métodos , Nanopartículas del Metal/uso terapéutico , Metotrexato/administración & dosificación , Nanocápsulas/administración & dosificación , Fototerapia/métodos , Animales , Antirreumáticos/administración & dosificación , Terapia Combinada , Nanopartículas del Metal/química , Ratones , Resultado del Tratamiento
7.
Bioorg Med Chem Lett ; 21(19): 5726-9, 2011 Oct 01.
Artículo en Inglés | MEDLINE | ID: mdl-21873054

RESUMEN

Compounds having α,ß-unsaturated lactones display a variety of biological activities. Many research groups have tested both natural and unnatural α,ß-unsaturated lactones for as-yet undiscovered biological properties. We synthesized α,ß-unsaturated lactones with various substituents at the δ-position and studied their immunosuppressive effects, that is, the inhibition of Interleukin-2 (IL-2) production. Among the compounds synthesized, the benzofuran-substituted α,ß-unsaturated lactone 4h showed the best inhibitory activity toward IL-2 production in Jurkat e6-1 T lymphocytes (IC(50)=66.9 nM) without cytotoxicity at 10 µM. The results indicated that 4h may be useful as a potent immunosuppressive agent, as well as in IL-2-related studies.


Asunto(s)
Inmunosupresores/síntesis química , Lactonas/síntesis química , Pruebas Inmunológicas de Citotoxicidad , Evaluación Preclínica de Medicamentos , Humanos , Inmunosupresores/metabolismo , Inmunosupresores/farmacología , Inflamación/tratamiento farmacológico , Concentración 50 Inhibidora , Interleucina-2/biosíntesis , Células Jurkat , Lactonas/metabolismo , Lactonas/farmacología , Estructura Molecular , Relación Estructura-Actividad , Linfocitos T/metabolismo
9.
J Pain ; 11(8): 789-97, 2010 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-20338821

RESUMEN

UNLABELLED: Mindfulness involves reducing potential influences from aversive cognitions, sensations, and emotions on behavior. Mindfulness may influence the experience of pain-related anxiety, and thereby enhance other aspects of physical and psychosocial functioning. Thus, the purpose of this study was to investigate a potential mediating role of pain-related anxiety between mindfulness and physical and psychosocial functioning in chronic pain patients. This cross-sectional/correlational study used archival data (N = 226) obtained from the larger Korean Pain Study at a university-based pain-management center in Korea. Based on the inclusion criterion for the present study, archival data were analyzed for a final sample of 179 patients with chronic pain. Structural equation analyses showed that both the partial- and full-mediation models had adequate goodness-of-fit indices for physical and psychosocial functioning. Subsequent chi-square tests, however, indicated that the more parsimonious full-mediation model was preferred to the partial-mediation model for physical and psychosocial functioning. Bootstrapping procedures yielded significant mediation effects of pain-related anxiety in the full-mediation models on physical and psychosocial functioning. These findings suggest that being mindful may lead indirectly to a decrease in the disabling influences of pain-related anxiety, thereby contributing to better physical and psychosocial functioning, rather than playing a direct contributing role for better functioning among chronic pain patients in Korea. PERSPECTIVE: This article examines the mediating role of pain-related anxiety between mindfulness and physical/psychosocial functioning. Results suggest that mindfulness methods may benefit patients having pain-related anxiety and consequent disability. These benefits may derive from the way processes of mindfulness interact with processes of avoidance and with cognitive influences on emotional suffering.


Asunto(s)
Ansiedad/psicología , Atención , Emociones , Dolor/psicología , Conducta Social , Adulto , Ansiedad/complicaciones , Enfermedad Crónica/psicología , Femenino , Humanos , Corea (Geográfico) , Masculino , Persona de Mediana Edad , Dolor/complicaciones , Dimensión del Dolor/métodos , Selección de Paciente , Encuestas y Cuestionarios
10.
J Agric Food Chem ; 56(14): 5942-6, 2008 Jul 23.
Artículo en Inglés | MEDLINE | ID: mdl-18572913

RESUMEN

Interesterification of a 60:40 (wt/wt) mixture of olive oil and fully hydrogenated canola oil was carried out in a batch reactor using a commercial immobilized lipase from Thermomyces lanuginose as a biocatalyst. The effects of a stepwise change of temperature on the degree of conversion, the solid fat content (SFC) of the products, and the residual activity of the enzyme were investigated. As a reference condition, an interesterification trial was conducted at a constant temperature of 70 degrees C for 48 h. For trials in which a temperature of 70 degrees C was used for the first 4 h of reaction and a temperature of 60 degrees C was employed for the following 44 h, there were no significant differences (p < 0.05) in the overall degree of conversion relative to the reference condition. Oils interesterified for only 1 or 2 h at 70 degrees C had melting points higher than 60 degrees C, whereas an oil produced by interesterification at 70 degrees C for only 4 h had a melting point of 58 degrees C. There was little difference (p < 0.05) between the SFC profiles of the interesterification products prepared by two different temperature protocols (70 degrees C for 24 h; 70 degrees C for 4 h followed by 60 degrees C for 20 h). Use of the protocol involving a step decrease in temperature significantly decreased catalyst deactivation effects, thereby increasing the residual activity of the immobilized lipase.


Asunto(s)
Ácidos Grasos Monoinsaturados/metabolismo , Lipasa/metabolismo , Aceites de Plantas/metabolismo , Estabilidad de Enzimas , Enzimas Inmovilizadas , Esterificación , Ácidos Grasos Monoinsaturados/química , Manipulación de Alimentos/métodos , Hidrogenación , Aceite de Oliva , Aceites de Plantas/química , Aceite de Brassica napus , Temperatura
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA